Status:
COMPLETED
Which Needle Length for Injecting Insulin
Lead Sponsor:
University Medical Center Groningen
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Background and aims: * In the Netherlands most patients with diabetes mellitus that are treated with insulin, use an insulin pen for insulin administration. The injection technique can influence the ...
Detailed Description
* In this randomised, clinical trial with cross-over design, 52 patients with Diabetes type 1 and 2 using a 8 or 12 mm needle, are randomised into two groups. * Group I starts using 5 mm needles for i...
Eligibility Criteria
Inclusion
- males and females diagnosed with diabetes Type 1 or 2
- using insulin for at least one year
- using an insulin pen and a needle of 8-mm or longer
- 18 years or older
- capable of reading the written information
- prepared to, and capable of signing an informed consent
Exclusion
- patients that
- change their own insulin dosage and don't keep an administration of these changes
- had an HbA1c that varied more than 15 % in the past year
- use a needle of 5 or 6-mm
- have hypoglycaemia unawareness
- are pregnant or wanted to become pregnant
- have a BMI \< 18
- have a skinfold thickness of 10 mm or less at the injection sites (abdomen and thigh)
- had hemoglobinopathies which could limit the ability of haemoglobin to be glycated
- had skin problems like lipodystrofie
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
End Date :
October 1 2004
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00292890
Start Date
January 1 2004
End Date
October 1 2004
Last Update
February 16 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Centre Groningen
Groningen, Provincie Groningen, Netherlands, 9700RB